Aurobindo Pharma Limited has informed the Exchange regarding a revised press release dated January 04, 2023, titled "Eugia Pharma receives USFDA approval for Azacitidine for Injection".
Press Release (Revised) Jan 04 2023
Filed with NSE ·
6ix hasn’t read this filing yet.
Earlier from Aurobindo Pharma
- Press Release Dec 27 2022
- Press Release Nov 23 2022
- Press Release Nov 18 2022
- Press Release Nov 12 2022
- Press Release Aug 24 2022
Later from Aurobindo Pharma
- Press Release Feb 07 2023
- Aurobindo Pharma Ltd Press Release Mar 08 2023
- Press Release Mar 30 2023
- Press Release May 26 2023
- Press Release May 27 2023
Follow Aurobindo Pharma into a list and get an email when it puts out news.
Follow Aurobindo Pharma